Aspira Womans Earnings Estimate

AWH
 Stock
  

USD 0.77  0.04  5.48%   

Many public companies, such as Aspira Womans, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Aspira Womans' earnings estimates, investors can diagnose different trends across Aspira Womans' analyst sentiment over time as well as compare current estimates against different timeframes.
Aspira Womans is projected to generate -0.29 in earnings per share on the 31st of December 2021. Aspira Womans earnings estimates module stress-tests analyst consensus about projected Aspira Womans Health EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please continue to Trending Equities.
  
Refresh
The current Gross Profit is estimated to increase to about 3.3 M, while Profit Margin is projected to decrease to (5.01) .

Aspira Womans Earnings Estimation Breakdown

Calculation of earning per share of Aspira Womans Health is based on official Zacks consensus of 2 analysts regarding Aspira Womans future annual earnings. Given the historical accuracy of 100.0%, the future earnings per share of Aspira Womans is estimated to be -0.29 with the lowest and highest values of -0.3 and -0.28, respectively. Please note that this consensus of annual earnings estimates for Aspira Womans Health is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.31
-0.3
Lowest
Expected EPS -0.29
-0.28
Highest

Aspira Womans Earnings Projection Consensus

Suppose the current estimates of Aspira Womans' value are higher than the current market price of the Aspira Womans stock. In this case, investors may conclude that Aspira Womans is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Aspira Womans' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

2

100.0%

-0.312

-0.29

Aspira Womans Earnings per Share Projection vs Actual

Actual Earning per Share of Aspira Womans refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Aspira Womans Health predict the company's earnings will be in the future. The higher the earnings per share of Aspira Womans, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Aspira Womans Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Aspira Womans, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Aspira Womans should always be considered in relation to other companies to make a more educated investment decision.

Aspira Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Aspira Womans' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-11
2022-03-31-0.08-0.080
2022-03-23
2021-12-31-0.08-0.080
2021-11-10
2021-09-30-0.07-0.09-0.0228 
2021-08-12
2021-06-30-0.06-0.060
2021-05-13
2021-03-31-0.1733-0.050.123371 
2021-03-25
2020-12-31-0.04-0.058-0.01845 
2020-11-12
2020-09-30-0.04-0.040
2020-08-13
2020-06-30None-0.04None
2020-04-07
2020-03-31None-0.04None
2020-03-26
2019-12-31None-0.0348None
2019-11-12
2019-09-30None-0.0393None
2019-08-08
2019-06-30None-0.0566None
2019-05-14
2019-03-31None-0.0492None
2019-03-28
2018-12-31None-0.0374None
2018-11-08
2018-09-30-0.03-0.04-0.0133 
2018-08-09
2018-06-30-0.04-0.040
2018-05-14
2018-03-31-0.04-0.05-0.0125 
2018-03-13
2017-12-31-0.04-0.05-0.0125 
2017-11-08
2017-09-30-0.04-0.06-0.0250 
2017-08-09
2017-06-30-0.04-0.040
2017-05-11
2017-03-31-0.04-0.05-0.0125 
2017-03-29
2016-12-31-0.05-0.050
2016-11-10
2016-09-30-0.06-0.07-0.0116 
2016-08-10
2016-06-30-0.09-0.070.0222 
2016-05-16
2016-03-31-0.09-0.090
2016-03-24
2015-12-31-0.11-0.10.01
2015-11-12
2015-09-30-0.1-0.10
2015-08-13
2015-06-30-0.09-0.11-0.0222 
2015-05-11
2015-03-31-0.1-0.10
2015-03-25
2014-12-31-0.08-0.11-0.0337 
2014-11-13
2014-09-30None-0.16None
2014-08-15
2014-06-30None-0.1549None
2014-05-16
2014-03-31None-0.1113None
2014-03-07
2013-12-31None-0.06None
2013-11-15
2013-09-30None-0.0985None
2013-08-15
2013-06-30None-0.1078None
2013-05-15
2013-03-31-0.15-0.17-0.0213 
2013-02-20
2012-12-31-0.12-0.090.0325 
2012-11-12
2012-09-30-0.21-0.130.0838 
2012-08-14
2012-06-30-0.2-0.25-0.0525 
2012-05-15
2012-03-31-0.25-0.140.1144 
2012-03-27
2011-12-31-0.26-0.210.0519 
2011-11-09
2011-09-30-0.36-0.310.0513 
2011-08-04
2011-06-30-0.34-0.39-0.0514 
2011-05-10
2011-03-31-0.34-0.340
2011-02-10
2010-12-31-0.34-0.230.1132 
2010-11-11
2010-09-30-0.36-0.240.1233 
2010-08-12
2010-06-30None-0.0677None
2010-05-29
2010-03-31None-1.1435None
2009-03-04
2008-12-31None-0.6705None
2008-11-14
2008-09-30None-0.7433None
2008-08-14
2008-06-30None-0.6991None
2008-05-15
2008-03-31None-0.7595None
2008-03-05
2007-12-31None-0.5161None
2007-11-13
2007-09-30None-1.0648None
2007-08-14
2007-06-30None-1.7388None
2007-05-16
2007-03-31None-1.5413None
2007-02-23
2006-12-31None-0.491None
2006-11-07
2006-09-30None-1.9448None
2006-08-14
2006-06-30-2-20
2006-05-04
2006-03-31-2-1.40.630 
2006-02-16
2005-12-31-2.4-2.20.2
2005-12-21
2005-09-30-2.65-2.30.3513 
2005-08-08
2005-06-30-2.67-3.1-0.4316 
2005-05-05
2005-03-31-3-3.2-0.2
2005-02-17
2004-12-31-2.67-2.60.07
2004-11-01
2004-09-30-3.43-3.30.13
2004-07-29
2004-06-30-2.98-4.5-1.5251 
2004-05-06
2004-03-31-2.42-2.6-0.18
2004-02-17
2003-12-31-2.15-2.3-0.15
2003-10-30
2003-09-30-1.78-1.8-0.02
2003-07-24
2003-06-30-2.3-3-0.730 
2003-04-24
2003-03-31-3.2-3.4-0.2
2003-02-13
2002-12-31-2.4-2.5-0.1
2002-10-31
2002-09-30-2.5-2.9-0.416 
2002-08-05
2002-06-30-2.7-2.70
2002-04-25
2002-03-31-2.9-2.70.2
2002-02-14
2001-12-31-2.9-2.70.2
2001-10-25
2001-09-30-2.6-2.60
2001-07-26
2001-06-30-2.5-2.20.312 
2001-03-31
2001-03-31None-2.273None
2001-02-15
2000-12-31-1.57-1.9-0.3321 
2000-09-30
2000-09-30None-8.8971None

About Aspira Womans Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Aspira Womans earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Aspira Womans estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Aspira Womans fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-471.7 M-509 M
Earning Before Interest and Taxes EBIT-31.6 M-32.4 M
Earnings per Basic Share(0.28) (0.30) 
Earnings per Diluted Share(0.28) (0.30) 
Price to Earnings Ratio(6.32) (6.82) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-31.3 M-32.1 M
Earnings before Tax-31.7 M-32.5 M
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aspira Womans without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Pair Trading with Aspira Womans

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womans position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womans will appreciate offsetting losses from the drop in the long position's value.

Aspira Womans Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Aspira Womans could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womans when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womans - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womans Health to buy it.
The correlation of Aspira Womans is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womans moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womans Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womans can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
82.2 M
Quarterly Revenue Growth YOY
0.27
Return On Assets
-0.48
Return On Equity
-0.95
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.